14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 12, 2024 Buy 15 000 Neupert Peter M Common Stock
Mar 12, 2024 Sell 15 000 Neupert Peter M Stock Option (right to buy)
Mar 05, 2024 Sell 7 727 Piskel Kyle Common Stock
Mar 05, 2024 Sell 6 772 Taylor Stacy L Common Stock
Mar 05, 2024 Sell 6 609 Taylor Stacy L Common Stock
Mar 05, 2024 Sell 12 887 Lo Francis Common Stock
Mar 05, 2024 Sell 1 813 Lo Francis Common Stock
Mar 05, 2024 Sell 10 746 Benzeno Sharon Common Stock
Mar 05, 2024 Sell 18 644 Benzeno Sharon Common Stock
Mar 05, 2024 Sell 25 580 Rubinstein Julie Common Stock
Mar 05, 2024 Sell 13 490 Rubinstein Julie Common Stock
Mar 05, 2024 Sell 15 456 Peterson Tycho Common Stock
Mar 05, 2024 Sell 5 879 Robins Chad M Common Stock
Mar 05, 2024 Sell 42 794 Robins Chad M Common Stock
Mar 05, 2024 Sell 6 016 Bobulsky Susan Common Stock
Mar 05, 2024 Sell 6 975 Bobulsky Susan Common Stock
Mar 04, 2024 Buy 31 328 Pellini Michael J Common Stock
Mar 04, 2024 Buy 48 044 Pellini Michael J Stock Option (right to buy)
Mar 04, 2024 Buy 31 328 Owen Katey Einterz Common Stock
Mar 04, 2024 Buy 48 044 Owen Katey Einterz Stock Option (right to buy)
Mar 04, 2024 Buy 31 328 Neupert Peter M Common Stock
Mar 04, 2024 Buy 48 044 Neupert Peter M Stock Option (right to buy)
Mar 04, 2024 Buy 31 328 Hershberg Robert Common Stock
Mar 04, 2024 Buy 48 044 Hershberg Robert Stock Option (right to buy)
Mar 04, 2024 Buy 31 328 Griffin Michelle Renee Common Stock
Mar 04, 2024 Buy 48 044 Griffin Michelle Renee Stock Option (right to buy)
Mar 04, 2024 Buy 43 740 Piskel Kyle Common Stock
Mar 04, 2024 Buy 39 990 Taylor Stacy L Common Stock
Mar 04, 2024 Buy 60 010 Taylor Stacy L Stock Option (right to buy)
Mar 04, 2024 Buy 99 976 Lo Francis Common Stock
Mar 04, 2024 Buy 150 024 Lo Francis Stock Option (right to buy)
Mar 04, 2024 Buy 132 979 Benzeno Sharon Common Stock
Mar 04, 2024 Buy 199 549 Benzeno Sharon Stock Option (right to buy)
Mar 04, 2024 Buy 175 000 Rubinstein Julie Common Stock
Mar 04, 2024 Buy 354 610 Robins Harlan S Common Stock
Mar 04, 2024 Buy 147 790 Peterson Tycho Common Stock
Mar 04, 2024 Buy 354 610 Robins Chad M Common Stock
Mar 04, 2024 Buy 132 979 Bobulsky Susan Common Stock
Mar 04, 2024 Buy 199 549 Bobulsky Susan Stock Option (right to buy)
Jan 25, 2024 Buy 0 Bobulsky Susan Common Stock
Jan 25, 2024 Buy 5 000 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 20 000 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 28 750 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 13 474 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 20 000 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 22 894 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 102 965 Bobulsky Susan Stock Option (Right to Buy)
Jan 25, 2024 Buy 88 689 Bobulsky Susan Stock Option (Right to Buy)
Dec 13, 2023 Buy 100 000 Neupert Peter M Common Stock
Dec 13, 2023 Sell 100 000 Neupert Peter M Stock Option (right to buy)
Nov 16, 2023 Sell 259 Piskel Kyle Common Stock
Aug 08, 2023 Sell 10 550 Sood Nitin Common Stock
Aug 07, 2023 Sell 5 652 Sood Nitin Common Stock
Jun 20, 2023 Buy 134 961 Peterson Tycho Common Stock
Jun 20, 2023 Sell 70 000 Peterson Tycho Common Stock
Jun 20, 2023 Sell 134 961 Peterson Tycho Stock Option (right to buy)
Jun 20, 2023 Sell 64 961 Peterson Tycho Common Stock
Jun 15, 2023 Sell 14 328 Peterson Tycho Stock Option (right to buy)
Jun 15, 2023 Buy 14 328 Peterson Tycho Common Stock
Jun 15, 2023 Sell 14 328 Peterson Tycho Common Stock
Jun 02, 2023 Sell 38 000 Peterson Tycho Common Stock
Apr 11, 2023 Sell 2 308 Adams R Mark Common Stock
Apr 10, 2023 Sell 817 Adams R Mark Common Stock
Mar 27, 2023 Sell 2 341 Griffin Michelle Renee Common Stock
Mar 07, 2023 Sell 13 387 Taylor Stacy L Common Stock
Mar 07, 2023 Sell 17 155 Adams R Mark Common Stock
Mar 07, 2023 Sell 9 813 Sood Nitin Common Stock
Mar 06, 2023 Buy 23 329 Pellini Michael J Stock Option (right to buy)
Mar 06, 2023 Buy 14 775 Pellini Michael J Common Stock
Mar 06, 2023 Buy 14 775 Owen Katey Einterz Common Stock
Mar 06, 2023 Buy 23 329 Owen Katey Einterz Stock Option (right to buy)
Mar 06, 2023 Buy 23 329 Neupert Peter M Stock Option (right to buy)
Mar 06, 2023 Buy 14 775 Neupert Peter M Common Stock
Mar 06, 2023 Buy 14 775 Hershberg Robert Common Stock
Mar 06, 2023 Buy 23 329 Hershberg Robert Stock Option (right to buy)
Mar 06, 2023 Buy 23 329 Griffin Michelle Renee Stock Option (right to buy)
Mar 06, 2023 Buy 14 775 Griffin Michelle Renee Common Stock
Mar 06, 2023 Buy 23 329 Conroy Kevin T Stock Option (right to buy)
Mar 06, 2023 Buy 14 775 Conroy Kevin T Common Stock
Mar 06, 2023 Buy 14 775 Trigg Leslie Common Stock
Mar 06, 2023 Buy 23 329 Trigg Leslie Stock Option (right to buy)
Mar 06, 2023 Buy 43 735 Piskel Kyle Common Stock
Mar 06, 2023 Sell 3 300 Piskel Kyle Common Stock
Mar 06, 2023 Sell 229 Piskel Kyle Common Stock
Mar 06, 2023 Buy 85 697 Lo Francis Common Stock
Mar 06, 2023 Sell 6 816 Lo Francis Common Stock
Mar 06, 2023 Buy 128 599 Lo Francis Stock Option (right to buy)
Mar 06, 2023 Buy 85 697 Taylor Stacy L Common Stock
Mar 06, 2023 Sell 5 491 Taylor Stacy L Common Stock
Mar 06, 2023 Buy 128 599 Taylor Stacy L Stock Option (right to buy)
Mar 06, 2023 Buy 88 652 Adams R Mark Common Stock
Mar 06, 2023 Sell 6 529 Adams R Mark Common Stock
Mar 06, 2023 Buy 133 033 Adams R Mark Stock Option (right to buy)
Mar 06, 2023 Buy 118 203 Peterson Tycho Common Stock
Mar 06, 2023 Buy 177 377 Peterson Tycho Stock Option (right to buy)
Mar 06, 2023 Buy 132 979 Benzeno Sharon Common Stock
Mar 06, 2023 Sell 11 749 Benzeno Sharon Common Stock
Mar 06, 2023 Buy 199 549 Benzeno Sharon Stock Option (right to buy)
Mar 06, 2023 Buy 132 979 Sood Nitin Common Stock
Mar 06, 2023 Sell 6 661 Sood Nitin Common Stock
INSIDER POWER
69.454
Last 100 transactions
Buy: 4 775 554 | Sell: 736 023 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 69.454.

In total, the insiders bought 4 775 554 and sold 736 023 ADPT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Adeptus Health Inc

Adeptus Health Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a cli... ADPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT